CMA Stock Recent News

Comerica Incorporated (NYSE:CMA ) Q2 2025 Earnings Conference Call July 18, 2025 8:00 AM ET Company Participants R - Corporate Participant e - Corporate Participant g - Corporate Participant s - Corporate Participant e - Corporate Participant Curtis Chatman Farmer - Chairman, CEO & President James J. Herzog - CFO & Senior EVP Kelly Gage - Senior VP & Director of Investor Relations Melinda A.

The headline numbers for Comerica (CMA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Comerica Incorporated (CMA) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $1.53 per share a year ago.

DALLAS , July 18, 2025 /PRNewswire/ -- Comerica Incorporated (NYSE: CMA) has reported its second quarter 2025 financial results. The results are available on the Investor Relations section of Comerica's website here.

CMA's Q2 earnings may fall 19.6% despite revenue gains, as rising expenses and deposit declines weigh on results.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Comerica (CMA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.

I assign Comerica a hold rating, reflecting a balance between solid fundamentals and short-term risks constraining its outlook. Comerica's disciplined cost management supports stable margins and profitability, even as revenues face pressure from a challenging macro environment. Valuation appears fair, with no clear over or undervaluation, and my conservative DCF suggests limited upside under very conservative assumptions.

Comerica (CMA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The offer by seven of the UK's largest housebuilders to pay £100 million and agree to legally binding restrictions on sharing information with purported rivals to resolve a competition investigation was a "get out of jail free card", one analyst said.  Coming on the same day that Sir Brian Leveson published a report with various recommendations to help clear Britain's legal backlog, including calling for more out-of-court settlements, the housebuilders made a similar offer to the Competition and Markets Authority to avoid taking an ongoing investigation further.

The Competition and Markets Authority has started an investigation into Primary Health Properties PLC (LSE:PHP, OTC:PHPRF)' £1.79 billion bid to acquire Assura Group (LSE:AGR). In a statement, the CMA said it will look at whether the deal creates a relevant merger situation and if it could hurt competition in the UK healthcare property markets.